Roche’s breast cancer drug Perjeta wins EU panel support

Posted: December 17th, 2012  |  Company/topic: Roche
Website: BIO SmartBrief
A European Medicines Agency committee recommended that Roche Holding's Perjeta, or pertuzumab, in combination with Herceptin  -More- …
Tags: , , , , ,

Sanofi (France) Diabetes Drug Wins EU Panel Recommendation

Posted: November 20th, 2012  |  Company/topic: Sanofi
Website: BioSpace.com Featured News
Sanofi has received a recommendation for European approval of once-daily Lyxumia for the treatment of adults with type 2 diabetes mellitus. The European Medicines Agency's Committee for Medicinal Prod…
Tags: , , , , ,

FDA Panel Backs Novo Nordisk A/S Diabetes Drugs

Posted: November 9th, 2012  |  Company/topic: Novo Nordisk
Website: BioSpace.com Featured News
WASHINGTON, Nov. 8, 2012 /PRNewswire/ -- Novo Nordisk today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the United States Food and Drug Administration (FDA) has complet…
Tags: , , , , ,

GSK’s anthrax drug raxibacumab wins support of FDA panel

Posted: November 6th, 2012  |  Company/topic: GlaxoSmithKline
Website: BIO SmartBrief
An FDA advisory panel recommended the approval of GlaxoSmithKline's monoclonal antibody raxibacumab as a therapy for inhalati -More- …
Tags: , , , ,